Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis: A Double-blind, Vehicle-Controlled Phase 2a Randomized Clinical Trial.
- Resource Type
- Article
- Authors
- Zirwas, Matthew J.; Draelos, Zoe D.; DuBois, Janet; Kircik, Leon H.; Moore, Angela Y.; Stein Gold, Linda; Alonso-Llamazares, Javier; Bukhalo, Michael; Bruce, Suzanne; Eads, Kimmie; Green, Lawrence J.; Guenthner, Scott T.; Ferris, Laura K.; Forman, Seth B.; Kempers, Steven E.; Lain, Edward; Lynde, Charles W.; Pariser, David M.; Toth, Darryl P.; Yamauchi, Paul S.
- Source
- JAMA Dermatology; Jun2023, Vol. 159 Issue 6, p613-620, 8p
- Subject
- Language
- ISSN
- 21686068